RB
Revascular Bio Co., Ltd.
Japan · Biotech
Revascular Bio develops cell therapies using vascular endothelial stem cells.
Product
The Osaka University startup studies cells that help maintain and regenerate blood vessels. It aims to use those cells to address diseases involving impaired microcirculation and missing or defective proteins.
Development programmes include difficult-to-treat skin ulcers and haemophilia. Its work spans cell preparation, manufacturing methods and therapeutic research, building on academic studies of vascular regeneration.
Funding history
4 rounds · 2 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| FY2025 Go-Tech research and development grant | Undisclosed | Participants not disclosed | |
| FY2024 second MU-TECH research grant | ¥3M | Mitsubishi UFJ Technology Development Foundation — Participant | |
| AMED drug-discovery ecosystem grant | Undisclosed | Japan Agency for Medical Research and Development (AMED) — Participant | |
| OUVC2 investment | ¥220M | Osaka University Venture Capital — Participant |